DCF — FREEMAN OAK HILL HEALTH SYSTEM
Enterprise Value: $65.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$65.6M
Enterprise Value
$4.1M
PV of Cash Flows
$61.5M
PV of Terminal Value
$99.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $605.2M | $21.1M | 3.0% | $-6.0M | $-5.5M |
| Year 2 | $623.3M | $27.9M | 4.0% | $-1.5M | $-1.3M |
| Year 3 | $642.0M | $35.2M | 5.0% | $3.2M | $2.4M |
| Year 4 | $661.3M | $39.5M | 6.0% | $5.8M | $4.0M |
| Year 5 | $681.1M | $42.4M | 6.0% | $7.2M | $4.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $65.6M. Terminal value accounts for 94% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$587.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.029793693247838336
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5